BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22440874)

  • 1. Temozolomide and other potential agents for the treatment of glioblastoma multiforme.
    Nagasawa DT; Chow F; Yew A; Kim W; Cremer N; Yang I
    Neurosurg Clin N Am; 2012 Apr; 23(2):307-22, ix. PubMed ID: 22440874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Temozolomide in patients with a glioblastoma multiforme: new developments].
    Bromberg JE; Postma TJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1376-8. PubMed ID: 15997689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temozolomide in second-line treatment after prior nitrosurea-based chemotherapy in glioblastoma multiforme: experience from a Portuguese institution.
    Teixeira MM; Garcia I; Portela I; Cernuda M; Oliveira C; Albano J; Lima L
    Int J Clin Pharmacol Res; 2002; 22(1):19-22. PubMed ID: 12395915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme.
    Chamberlain MC; Tsao-Wei DD
    Cancer; 2004 Mar; 100(6):1213-20. PubMed ID: 15022289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temozolomide in glioblastoma multiforme of the elderly.
    Brandes AA; Vastola F; Basso U; Pasetto LM; Ermani M; Berti F; Rotilio A; Amistà P; Scienza R; Monfardini S
    Tumori; 2002; 88(1 Suppl 1):S69-70. PubMed ID: 11989929
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment-related Acute Myeloid Leukaemia After Temozolomide for Glioblastoma Multiforme.
    Tan CW; See SJ; Tham CK; Ang AL
    Ann Acad Med Singap; 2014 Jun; 43(6):334-7. PubMed ID: 25028145
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations.
    Chinot OL; Barrie M; Frauger E; Dufour H; Figarella-Branger D; Palmari J; Braguer D; Hoang-Xuan K; Moktari K; Peragut JC; Martin PM; Grisoli F
    Cancer; 2004 May; 100(10):2208-14. PubMed ID: 15139066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status quo--standard-of-care medical and radiation therapy for glioblastoma.
    Becker KP; Yu J
    Cancer J; 2012; 18(1):12-9. PubMed ID: 22290252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide-related acute lymphoblastic leukemia with translocation (4;11)(q21;q23) in a glioblastoma patient.
    Chou KN; Lin YC; Liu MY; Chang PY
    J Clin Neurosci; 2014 Apr; 21(4):701-4. PubMed ID: 24291476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide and treatment of malignant glioma.
    Friedman HS; Kerby T; Calvert H
    Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for glioblastoma multiforme (GBM).
    Roitberg B
    Surg Neurol; 2006 Feb; 65(2):107-8. PubMed ID: 16427394
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiotherapy with concurrent or sequential temozolomide in elderly patients with glioblastoma multiforme.
    Hashem SA; Salem A; Al-Rashdan A; Ezam N; Nour A; Alsharbaji A; Rejeeth C; Mohamad I; Sughayer M; Elyan M; Al-Hussaini M; Addasi A; Almousa A
    J Med Imaging Radiat Oncol; 2012 Apr; 56(2):204-10. PubMed ID: 22498195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of temozolomide in newly-diagnosed glioblastoma multiforme.
    Jenkinson MD
    Br J Neurosurg; 2008 Jun; 22(3):456. PubMed ID: 18568743
    [No Abstract]   [Full Text] [Related]  

  • 14. Going past the data for temozolomide.
    Villano JL; Letarte N; Bressler LR
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):1113-5. PubMed ID: 22147076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problems of Glioblastoma Multiforme Drug Resistance.
    Stavrovskaya AA; Shushanov SS; Rybalkina EY
    Biochemistry (Mosc); 2016 Feb; 81(2):91-100. PubMed ID: 27260389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Results of a Survey of Prolonged Adjuvant Treatment with Temozolomide in Patients with Glioblastoma (SV3 Study).
    Rivoirard R; Falk AT; Chargari C; Guy JB; Mery B; Nuti C; Peoc'h M; Forest F; Garin C; Adjabi A; Hoarau D; Kawaye S; Almokhles H; Fournel P; Magné N
    Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):486-7. PubMed ID: 25963856
    [No Abstract]   [Full Text] [Related]  

  • 17. Glioblastoma: If this is the "Temozolomide Era" Where is the Evidence?
    Perry JR
    Can J Neurol Sci; 2014 May; 41(3):301-2. PubMed ID: 24718814
    [No Abstract]   [Full Text] [Related]  

  • 18. NICE verdict on Temozolomide: where next?
    Brada M
    Br J Cancer; 2002 Feb; 86(4):499-500. PubMed ID: 11870526
    [No Abstract]   [Full Text] [Related]  

  • 19. Temozolomide (Temodal) for treatment of primary brain tumours.
    MacConnachie AM
    Intensive Crit Care Nurs; 2000 Feb; 16(1):59-60. PubMed ID: 10790718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six year survival after prolonged temozolomide treatment in a 30-year-old patient with glioblastoma.
    Poelen J; Prick MJ; Jeuken JW; Wesseling P; Bernsen HJ
    Acta Neurol Belg; 2009 Sep; 109(3):238-42. PubMed ID: 19902821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.